Small animals models for drug discovery

被引:0
|
作者
Martin, James G. [1 ]
Novali, Mauro [1 ]
机构
[1] McGill Univ, Meakins Christie Labs, Montreal, PQ H2X 2P2, Canada
基金
加拿大健康研究院;
关键词
Asthma; Inflammation; Cytokines; Chemokines; Growth factors; Remodeling; Airway hyperresponsiveness; Therapy; AIRWAY SMOOTH-MUSCLE; LATE PULMONARY RESPONSES; NECROSIS-FACTOR-ALPHA; BROWN-NORWAY RATS; REPEATED ALLERGEN EXPOSURE; ACTIVATED PROTEIN-KINASE; GOBLET CELL HYPERPLASIA; T-CELLS; MURINE MODEL; DENDRITIC CELLS;
D O I
10.1016/j.pupt.2011.05.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
There has been an explosion of studies of animal models of asthma in the past 20 years. The elucidation of fundamental immunological mechanisms underlying the development of allergy and the complex cytokine and chemokines networks underlying the responses have been substantially unraveled. Translation of findings to human asthma have been slow and hindered by the varied phenotypes that human asthma represents. New areas for expansion of modeling include virally mediated airway inflammation, oxidant stress, and the interactions of stimuli triggering innate immune and adaptive immune responses. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:513 / 524
页数:12
相关论文
共 50 条
  • [41] Cell models and drug discovery for mitochondrial diseases
    Hu, Shuang-yi
    Zhuang, Qian-qian
    Qiu, Yue
    Zhu, Xu-fen
    Yan, Qing-feng
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2019, 20 (05): : 449 - 456
  • [42] Zebrafish models in neuropsychopharmacology and CNS drug discovery
    Khan, Kanza M.
    Collier, Adam D.
    Meshalkina, Darya A.
    Kysil, Elana V.
    Khatsko, Sergey L.
    Kolesnikova, Tatyana
    Morzherin, Yury Yu
    Warnick, Jason E.
    Kalueff, Allan V.
    Echevarria, David J.
    BRITISH JOURNAL OF PHARMACOLOGY, 2017, 174 (13) : 1925 - 1944
  • [43] Beyond Deterministic Models in Drug Discovery and Development
    Irurzun-Arana, Itziar
    Rackauckas, Christopher
    McDonald, Thomas O.
    Troconiz, Inaki F.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2020, 41 (11) : 882 - 895
  • [44] Mouse models for mesothelioma drug discovery and development
    Seastedt, Kenneth P.
    Pruett, Nathanael
    Hoang, Chuong D.
    EXPERT OPINION ON DRUG DISCOVERY, 2021, 16 (06) : 697 - 708
  • [45] Use of animal models for genomic drug discovery
    Tsujimoto, G
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 100 : 54P - 54P
  • [46] Organoid Models of Glioblastoma and Their Role in Drug Discovery
    Rybin, Matthew J.
    Ivan, Michael E.
    Ayad, Nagi G.
    Zeier, Zane
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2021, 15
  • [47] Transgenic Mouse Models of Tauopathy in Drug Discovery
    Noble, W.
    Hanger, D. P.
    Gallo, J. -M.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2010, 9 (04) : 403 - 428
  • [48] Models of retinal diseases and their applicability in drug discovery
    Malek, Goldis
    Busik, Julia
    Grant, Maria B.
    Choudhary, Mayur
    EXPERT OPINION ON DRUG DISCOVERY, 2018, 13 (04) : 359 - 377
  • [49] Utility of homology models in the drug discovery process
    Hillisch, A
    Pineda, LF
    Hilgenfeld, R
    DRUG DISCOVERY TODAY, 2004, 9 (15) : 659 - 669
  • [50] Animal models of skin disease for drug discovery
    Avci, Pinar
    Sadasivam, Magesh
    Gupta, Asheesh
    De Melo, Wanessa C. M. A.
    Huang, Ying-Ying
    Yin, Rui
    Chandran, Rakkiyappan
    Kumar, Raj
    Otufowora, Ayodeji
    Nyame, Theodore
    Hamblin, Michael R.
    EXPERT OPINION ON DRUG DISCOVERY, 2013, 8 (03) : 331 - 355